|
IQVIA™ Real-World Insights Bibliography
| Cost-effectiveness analysis of empagliflozin compared with glimepiride in patients with Type 2 diabetes in China |
| Author(s): Ahmed Salem 1, Peng Men 2 3, Mafalda Ramos 4, Yan-Jun Zhang 5, Anastasia Ustyugova 6, Mark Lamotte 7 |
| Affiliations(s): 1IQVIA, Real World Solutions, Zaventem 1930, Belgium.
2Department of Pharmacy, Peking University Third Hospital, Beijing 100191, China.
3Institute for Drug Evaluation, Peking University Health Science Center, Beijing 100191, China.
4IQVIA, Global HEOR, Porto Salvo 2740-266, Portugal.
5Boehringer Ingelheim, Health Economics & Outcomes Research, Government Affairs & Market Access, Shanghai 200040, China.
6Boehringer Ingelheim, CardioMetabolism Respiratory, Ingelheim am Rhein 55216, Germany.
7IQVIA, Global HEOR, Zaventem 1930, Belgium. |
Publication(s): Journal of Comparative Effectiveness Research 2021 https://doi.org/10.2217/cer-2020-0284.
PMID: 33576249 DOI: 10.2217/cer-2020-0284
|
| Document Type(s): Article, |
| Countries: China, |
| Click here for the abstract |
C:
Y: |
Diabetes, Health economics,
2021 |
|
L:
A: |
English
Clinical setting: Primary care, Cost effectiveness, |
|
 |
| |
| |
| Potential clinical and economic impact of optimised maintenance therapy on discharged patients with COPD after hospitalisation for an exacerbation in China |
| Author(s): Ahmed Salem # 1, Heng Zhong # 2, Mafalda Ramos 1, Mark Lamotte 1, Hao Hu 3
|
| Affiliations(s): 1Real World Evidence, IQVIA, Zaventem, Belgium.
2R&D China, AstraZeneca R&D, Shanghai, China.
3Institute of Chinese Medical Sciences, University of Macau, Macau, China haohu@um.edu.mo.
#Contributed equally. |
Publication(s): BMJ Open 2021;11:e043664. doi:10.1136/bmjopen-2020-043664
e043664. doi:10.1136/bmjopen-2020-043664
PMID: 33910947 PMCID: PMC8094343 DOI: 10.1136/bmjopen-2020-043664
|
| Document Type(s): Article, |
| Countries: Belgium, China, |
| Click here for the abstract |
C:
Y: |
Health economics, Respiratory disease,
2021 |
|
L:
A: |
English
Clinical setting: Primary care, Cost effectiveness, |
|
|
| |
| |
| The Burden Of Hpv In Head And Neck Cancers - Design Of The Broaden Study |
| Author(s): Gómez Ulloa D1, Morais E2, Fenoll R1, Kothari S3, Giuliano A4, Mirghani H5, Mehanna H6, Waterboer T7, Roberts C3, Varga S3, Tu Y3, Pérez G3, Saah A3, Alemany L8 |
| Affiliations(s): 1 IQVIA, Barcelona, Spain 2 MSD, CORE, Lyon, France 3 Merck & Co. Inc., Center for Observational and Real-world Evidence, Kenilworth, NJ, US 4 Moffitt Cancer Center and Research Institute, Center for Immunization and Infection Research in Cancer, Tampa, FL, US 5 HEGP, ORL, Paris, France 6 InHANSE, Head and Neck Surgery, Birmingham, UK 7 German Cancer Research Center (DKFZ), Infections and Cancer Epidemiology, Heidelberg, Germany 8 Catalan Institute of Oncology - IDIBELL, On behalf of Unit of Cancer and Infection in the Cancer Epidemiology Research Programme, Hospitalet Del Llobregat, Spain |
Publication(s): IPVC, Barcelona, Spain, 23-27 March 2020
|
| Document Type(s): Oral presentation, |
| Countries: China, France, Germany, Italy, Japan, Portugal, Spain, |
C:
Y: |
Infectious disease, Oncology,
2020 |
|
L:
A: |
English
Burden of illness, Observational study, Retrospective Field Study, |
|
|
| |
| |
| Projected long-term clinical benefit and cost-effectiveness of empagliflozin compared to glimepiride in patients with type 2 diabetes in China |
| Author(s): Lamotte M1, Salem A2, Mettam S2, Ustyugova A2, Zhang YJ3, Ramos M1 |
| Affiliations(s): 1 IQVIA, Zaventem, Belgium 2 Boehringer Ingelheim International, GmbH, Germany 3 Boehringer Ingelheim, Beijing, China |
Publication(s): ADA, San Francisco, US, 07-11 June 2019
|
| Document Type(s): Poster, |
| Countries: China, |
| Click here for the abstract |
C:
Y: |
Diabetes,
2019 |
|
L:
A: |
English
Cost effectiveness, Population Based Study, |
|
|
| |
| |
| Contrasting three type 2 diabetes cardiovascular risk equations for East Asia with UKPDS82 using the IQIVA core diabetes model |
| Author(s): Olivieri A1, Ramos M2, Monteiro S3, Altrabsheh E3, Gurjar K4, Lamotte M2 |
| Affiliations(s): 1 IQVIA, Basel, Switzerland 2 IQVIA, Zaventem, Belgium 3 IQVIA, London, UK 4 IQVIA, Gurgaon, India |
Publication(s): ISPOR, New Orleans, 18-22 May 2019
|
| Document Type(s): Poster, |
| Countries: China, |
C:
Y: |
Diabetes,
2019 |
|
L:
A: |
English
Cost effectiveness, Population Based Study, |
|
|
| |
| |
| Natural hisotry of oral human papillomavirus infection in healthy populations: Design of the Prevalence of Oral HPV infection, a Global assessment, THE PROGRESS STUDY |
| Author(s): Pedros M1, Morais E2, Roset M1, Kothari S3, Alemany L5, Mirghani H6, Mehanna H7, Waterboer T8, Roberts C3, Vendetti N3, Walia A3, Drury R2, Luxembourg A3, Giuliano A9 |
| Affiliations(s): 1 IQVIA, Barcelona, Spain 2 MSD, Lyon, France 3 Merck & Co, Inc., Kenilworth, NJ, US 5 Catalan Institute of Oncology, Cancer Epidemiology Research Program and IDIBELL i CIBERESP, Barcelona, Spain 6 Hôpital Européen Georges-Pompidou Université Paris-Descartes, Paris, France 7 Institute of Head & Neck Studies and Education (InHANSE), University of Birmingham, Birmingham, United kingdom 8 German Cancer Research Center (DKFZ), Heidelberg, Germany 9 Moffitt Cancer Center, Florida, US |
Publication(s): EUROGIN, Monaco, France, 4-7 December 2019
|
| Document Type(s): Oral presentation, |
| Countries: China, France, Germany, Italy, Japan, Spain, UK, USA, |
| Click here for the abstract |
C:
Y: |
Clinical practice, Infectious disease, Methodology,
2019 |
|
L:
A: |
English
Epidemiological study, Observational study, Population Based Study, |
|
|
| |
| |
| Assessing the Burden of Type 2 Diabetes in China Considering the Current Status-Quo Management and Implications of Improved Management Using a Modeling Approach |
| Author(s): Foos V1, Wang K2, McEwan P3, Zhang Y2, Xin P2, Jiang X2, Qu S4, Xiong T4, De Moor R1, Ramos M1, Lamotte M1, Ji L5 |
| Affiliations(s): 1 IQVIA, Zaventem, Belgium 2 Lilly Suzhou Pharmaceutical Co, Ltd, Shanghai, China 3 Centre for Health Economics, Swansea University, Wales, England, UK 4 RWE Solutions & HEOR, QuintilesIMS, Shanghai, China 5 Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing, China |
Publication(s): Value Health Reg Issues. 2019 May;18:36-46.
|
| Document Type(s): Article, |
| Countries: China, |
| Click here for the abstract |
C:
Y: |
Diabetes, Health economics,
2019 |
|
L:
A: |
English
Cost effectiveness, |
|
|
| |
| |
| Cost-effectiveness of de-escalation from micafungin versus escalation from fluconazole for systemic candida infections in China |
| Author(s): Dechang Chen, Xianyao Wan, Eliza Kruger, Can Chen, Xiaomeng Yue, Liang Wang, Jiuhong Wu |
| Affiliations(s): IQVIA, Department of Critical Care Medicine, Shanghai Ruijin Hospital Affiliated To Jiaotong University, School of Medicine, Shanghai |
Publication(s): Journal of Medical Economics
|
| Document Type(s): Article, |
| Countries: China, |
| Click here for the abstract |
C:
Y: |
Health economics, Infectious disease,
2018 |
|
L:
A: |
English
Cost effectiveness, |
|
|
| |
| |
| Profiling and treatment patterns in NSCLC patients with CNS (brain) metastases in Europe and Asia |
| Author(s): Mari E1, Mpima S2, Guglielmetti F1, Nasuti P2, Manuguid F2, Heitner Enschede S3 |
| Affiliations(s): 1IQVIA , Milan, Italy 2IQVIA , London, UK 3IQVIA Inc, USA |
| Publication(s): |
| Document Type(s): |
| Countries: China, France, Germany, Italy, Japan, South Korea, Spain, UK, |
| Click here for the abstract |
C:
Y: |
2018 |
|
L:
A: |
English
|
|
|
| |
| |
| Patterns of care and of biomolecular characterization of Right, Transverse, and Left Colorectal Cancer from real-life evidence in Asia Pacific and European countries |
| Author(s): Ettore M1, Mpima S2, Guglielmetti F1, Nasuti P2 |
| Affiliations(s): 1IQVIA , Milan, Italy 2IQVIA , London, UK |
Publication(s): ESMO 2018
|
| Document Type(s): Poster, |
| Countries: China, France, Germany, Italy, Japan, South Korea, Spain, UK, |
| Click here for the abstract |
C:
Y: |
Oncology,
2018 |
|
L:
A: |
English
|
|
|
| |
| |
 1 of 4 
|
|
